FRLN - Freeline Therapeutics - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

0.00

Cash

123.6M

Avg Qtr Burn

N/A

Short % of Float

0.09%

Insider Ownership

1.10%

Institutional Own.

45.88%

Qtr Updated

03/31/24

Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
FLT201 Details Genetic disorder, Gaucher disease	Phase 1/2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
FLT180a (AAVS3 capsid) Details Hemophilia	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
FLT190 Details Genetic disorder, Fabry disease	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.